Literature DB >> 25929342

Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia.

Eoin P Flanagan1, Joseph R Duffy2, Jennifer L Whitwell3, Prashanthi Vemuri3, Dennis W Dickson4, Keith A Josephs1.   

Abstract

Classifying primary progressive aphasia (PPA) into variants that may predict the underlying pathology is important. However, some PPA patients cannot be classified. A 78-year-old woman had unclassifiable PPA characterized by anomia, dysarthria, and apraxia of speech without agrammatism. Magnetic resonance imaging revealed left mesial temporal atrophy and 18-flourodeoxy-glucose positron emission tomography showed left anterior temporal and posterior frontal (premotor) hypometabolism. Autopsy revealed a mixed tauopathy (argyrophilic grain disease) and transactive response-DNA-binding-protein-43 proteinopathy. Dual pathologies may explain the difficulty classifying some PPA patients and recognizing this will be important as new imaging techniques (particularly tau-positron emission tomography) are introduced and patients begin enrollment in clinical trials targeting the underlying proteinopathy.

Entities:  

Keywords:  TDP-43; argyrophilic grain disease; frontotemporal lobar degeneration; primary progressive aphasia; tau

Mesh:

Substances:

Year:  2015        PMID: 25929342      PMCID: PMC4628904          DOI: 10.1080/13554794.2015.1041534

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  14 in total

1.  Staging of argyrophilic grains: an age-associated tauopathy.

Authors:  Yuko Saito; Nyoka N Ruberu; Motoji Sawabe; Tomio Arai; Noriko Tanaka; Yukio Kakuta; Hiroshi Yamanouchi; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

2.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

3.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

4.  Argyrophilic grains: a distinct disease or an additive pathology?

Authors:  Keith A Josephs; Jennifer L Whitwell; Joseph E Parisi; David S Knopman; Bradley F Boeve; Yonas E Geda; Clifford R Jack; Ronald C Petersen; Dennis W Dickson
Journal:  Neurobiol Aging       Date:  2006-12-26       Impact factor: 4.673

5.  An empirically derived short form of the Boston naming test.

Authors:  A E Lansing; R J Ivnik; C M Cullum; C Randolph
Journal:  Arch Clin Neuropsychol       Date:  1999-08       Impact factor: 2.813

6.  Prediction of pathology in primary progressive language and speech disorders.

Authors:  V Deramecourt; F Lebert; B Debachy; M A Mackowiak-Cordoliani; S Bombois; O Kerdraon; L Buée; C-A Maurage; F Pasquier
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

7.  The northwestern anagram test: measuring sentence production in primary progressive aphasia.

Authors:  Sandra Weintraub; M-Marsel Mesulam; Christina Wieneke; Alfred Rademaker; Emily J Rogalski; Cynthia K Thompson
Journal:  Am J Alzheimers Dis Other Demen       Date:  2009-08-21       Impact factor: 2.035

Review 8.  Argyrophilic grain disease.

Authors:  Isidro Ferrer; Gabriel Santpere; Fred W van Leeuwen
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

9.  Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease.

Authors:  Hiroshige Fujishiro; Hirotake Uchikado; Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Osamu Yokota; Kuniaki Tsuchiya; Takashi Togo; Eizo Iseki; Yoshio Hirayasu
Journal:  Acta Neuropathol       Date:  2008-11-28       Impact factor: 17.088

10.  Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology.

Authors:  Francesca Caso; Benno Gesierich; Maya Henry; Manu Sidhu; Amanda LaMarre; Miranda Babiak; Bruce L Miller; Gil D Rabinovici; Eric J Huang; Giuseppe Magnani; Massimo Filippi; Giancarlo Comi; William W Seeley; Maria Luisa Gorno-Tempini
Journal:  Behav Neurol       Date:  2013       Impact factor: 3.342

View more
  5 in total

1.  Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia.

Authors:  Rene L Utianski; Hugo Botha; Peter R Martin; Christopher G Schwarz; Joseph R Duffy; Heather M Clark; Mary M Machulda; Alissa M Butts; Val J Lowe; Clifford R Jack; Matthew L Senjem; Anthony J Spychalla; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain Lang       Date:  2019-08-13       Impact factor: 2.381

2.  Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.

Authors:  Eun-Joo Kim; Jesse A Brown; Jersey Deng; Ji-Hye L Hwang; Salvatore Spina; Zachary A Miller; Mary G DeMay; Victor Valcour; Anna Karydas; Eliana Marisa Ramos; Giovanni Coppola; Bruce L Miller; Howard J Rosen; William W Seeley; Lea T Grinberg
Journal:  J Neurol       Date:  2018-10-15       Impact factor: 4.849

Review 3.  The Role of TDP-43 in Neurodegenerative Disease.

Authors:  Yan-Zhe Liao; Jing Ma; Jie-Zhi Dou
Journal:  Mol Neurobiol       Date:  2022-05-02       Impact factor: 5.590

Review 4.  Primary Progressive Aphasias and Apraxia of Speech.

Authors:  Hugo Botha; Keith A Josephs
Journal:  Continuum (Minneap Minn)       Date:  2019-02

5.  A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Nha Trang Thu Pham; Julie Stierwalt; Farwa Ali; Marina Buciuc; Matthew Baker; Cristhoper H Fernandez De Castro; Anthony J Spychalla; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; Eileen H Bigio; Ross R Reichard; Eric J Polley; Nilufer Ertekin-Taner; Rosa Rademakers; Michael A DeTure; Owen A Ross; Dennis W Dickson; Jennifer L Whitwell
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.